SCHEMBL27612641

SCHEMBL27612641

COC(=O)N1c2cc(N)ccc2CN1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.42
BRD4 O60885 1/20 0.38
ATAD2 Q6PL18 1/20 0.38
HSD17B3 P37058 1/20 0.38
RAD52 P43351 3/20 0.38
GFER P55789 2/20 0.38
GAA P10253 2/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.35
HRH4 Q9H3N8 2/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34
YWHAG P61981 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPK1 P28482 1/20 0.34
MMP8 P22894 2/20 0.34
MMP3 P08254 1/20 0.34
ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612810 0.88 NR1H2 (0.42) NR1H2BRD4ATAD2HSD17B3RAD52
SCHEMBL27612650 0.78 P2RX4 (0.44) HSD17B3KDM4EMAPTMEN1KMT2A
SCHEMBL29963540 0.75 BRD4 (0.51) NR1H2BRD4ATAD2HSD17B3KDM4E
SCHEMBL2306434 0.75 BRD4 (0.51) NR1H2BRD4ATAD2HSD17B3KDM4E
SCHEMBL4951654 0.71 MAPT (0.39) BRD4ATAD2HSD17B3RAD52GFER
SCHEMBL6295386 0.70 NR1H2 (0.60) NR1H2BRD4ATAD2HSD17B3RAD52
SCHEMBL27612686 0.70 ALDH1A1 (0.43) NR1H2BRD4ATAD2GFERGAA
SCHEMBL17099540 0.70 FSHR (0.39) NR1H2BRD4ATAD2HSD17B3RAD52
SCHEMBL25321379 0.69 KDM4E (0.59) NR1H2ATAD2HSD17B3KDM4EMAPT
SCHEMBL30475924 0.69 KDM4E (0.59) NR1H2ATAD2HSD17B3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed